Skip to main content
Clinical Trials/RBR-5qffrt
RBR-5qffrt
Completed
未知

Effects of treadmill walking training with additional body load in subjects with Parkinson's disease

niversidade Federal do Rio Grande do Norte0 sitesFebruary 2, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
eurological gait disorders, Parkinson's disease
Sponsor
niversidade Federal do Rio Grande do Norte
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 2, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal do Rio Grande do Norte

Eligibility Criteria

Inclusion Criteria

  • Idiopathic Parkinson's disease, diagnosed by a neurologist experienced in movement disorders, according to the criteria of brain bank in London;
  • Both sexes aged over 40 and less than 75 years;
  • In the moderate stage of disease (stages 2 and 3, according to the disability scale of Hoehn and Yahr modified) Use of antiparkinsonian medication;
  • Walk without any brace or assistive device to walk independently, a walkway of 8 meters (m);
  • Absence of other neurological disorders, musculoskeletal, cardiovascular and / or breathing that prevent treadmill gait training;
  • No visual changes and / or uncorrected hearing, that might interfere with the implementation of the Protocol;
  • Absence of severe cognitive impairment that prevented understanding of simple verbal instructions, as detected by the mini mental state examination;
  • Not having been subjected to surgery extereotáxica;
  • Signing the consent form (ICF).

Exclusion Criteria

  • Blood pressure (SBP) and systolic and diastolic values above, respectively, 200 mmHg and 110 mmHg before and / or after training;
  • Heart rate (HR) above the permitted submaximal values, calculated by formula \[FCsub \= 0\.75 x (220 \- age)];
  • Change in dose and / or the type of antiparkinsonian medication during the training period;
  • Presence of pain and / or severe muscle fatigue that prohibits continued the exercise.

Outcomes

Primary Outcomes

Not specified

Similar Trials